• Product NameCarbidopa Hydrate
• Brief DescriptionInhibitors
• Purification99.29%
• Biological ActivityAn inhibitor of DOPA decarboxylase, preventing conversion of levodopa to dopamine. It is used in parkinson disease to reduce peripheral adverse effects of levodopa. It has no antiparkinson actions by itself.
• Target NameDecarboxylase inhibitor
• CAS No. 38821-49-7
• Calculated MW 244.24
• Formulation C10H16N2O5
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Nervous system
  SMILES:C[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)NN.O
  Pathways:Metabolism
  Receptor:aromatic-L-amino-acid decarboxylase
  Boling pt:
  Melting pt:
  Solubility:DMSO: 10 mM
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Orlefors H, et al. Eur J Nucl Med Mol Imaging. 2006 Jan;33(1):60-5.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting